Literature DB >> 2914634

Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease.

J L Smith1, A R Opekun, E Larkai, D Y Graham.   

Abstract

To determine the relation between the sensation of pain in gastroesophageal reflux and the pH of the refluxate, we studied 25 individuals with symptomatic gastroesophageal reflux and positive Bernstein tests. We quantitatively assessed the sensitivity of the esophageal mucosa to pain associated with the intraesophageal infusion of eight different HCl solutions (pH 1, 1.5, 2, 2.5, 3, 4, 5, and 6). Test solutions were infused at 8 ml/min through an eight-lumen catheter with the orifices placed 5 cm above the lower esophageal sphincter. Each subject received all eight solutions in a double-blind randomized fashion. The time-to-pain onset increased with increasing pH; i.e., there was a highly significant difference between the time-to-pain and pH (p less than 0.001), with the time-to-pain significantly longer with increasing pH (r = 0.77). In addition to more rapid onset of pain, all subjects experienced pain with the pH 1 and 1.5 solutions, 80% had pain with the pH 2.0 solution, and half had pain with solutions of pH 2.5-6. Fifteen of these subjects underwent 24-h pH monitoring and these tests were examined for factors associated with pain. Only 64% of all pain episodes were associated with a pH drop of less than 4; the lowest pH obtained was not different between episodes with and without pain. Reflux episodes resulting in pain were significantly longer than those without pain and were more often associated with a recently preceding painful episode. Overall, none of the data from the 24-h pH monitoring was useful for predicting pain. The acid infusion studies and the 24-h pH data, taken together, suggest episodes of pain sensitize the patient for subsequent pain.

Entities:  

Mesh:

Year:  1989        PMID: 2914634

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Treatment of Refractory Gastroesophageal Reflux Disease.

Authors:  Rishi D Naik; Matthew H Meyers; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

Review 2.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

3.  Acid infusion into the esophagus increases the number of meal-induced transient lower esophageal sphincter relaxations (TLESRs) in healthy volunteers.

Authors:  J Halicka; P Banovcin; M Halickova; M Demeter; R Hyrdel; M Tatar; M Kollarik
Journal:  Neurogastroenterol Motil       Date:  2014-08-22       Impact factor: 3.598

Review 4.  What is potent acid inhibition, and how can it be achieved?

Authors:  Xavier Calvet; Fernando Gomollón
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus.

Authors:  R Fass; J M Yalam; L Camargo; C Johnson; H S Garewal; R E Sampliner
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

6.  Meal type affects heartburn severity.

Authors:  S Rodriguez; P Miner; M Robinson; B Greenwood; P N Maton; K Pappa
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

7.  Streamlining 24-hour pH study for GERD: Use of a 3-hour postprandial test.

Authors:  Amindra S Arora; Joseph A Murray
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

Review 8.  Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.

Authors:  Malcolm Robinson; John Horn
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Alkaline reflux oesophagitis.

Authors:  D L Stoker; J G Williams
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  Gastroesophageal reflux disease: medical or surgical treatment?

Authors:  Theodore Liakakos; George Karamanolis; Paul Patapis; Evangelos P Misiakos
Journal:  Gastroenterol Res Pract       Date:  2009-12-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.